Aclaris Therapeutics Reports Third Quarter 2023 Financial Results, Provides a Corporate Update
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced its financial results for the third quarter of 2023 and provided a corporate update.
Aclaris Therapeutics Reports Third Quarter 2023 Financial Results, Provides a Corporate Update Read More